Skip to main content
logo
CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,365.00
+85.00 (2.59%)
At close: Aug 11, 2026

CTCBIO Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
128,758123,769119,877137,878165,206140,318
Revenue Growth
6.09%3.25%-13.06%-16.54%17.74%7.91%
Gross Profit
52,17749,95949,23242,57054,05633,090
Operating Income
9,9536,250-5,014-4,57811,230-2,938
Net Income
6,1053,241-5,220-15,5884,704-7,318
Earnings Per Share
256.75135.54-218.00-652.00197.00-329.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19,16117,71119,17124,67924,3517,695
Total Debt
38,39538,74332,87035,28939,95840,656
Net Cash (Debt)
-19,234-21,032-13,698-10,610-15,607-32,961
Net Cash Growth
------
Net Cash Per Share
-808.88-879.69-572.03-443.76-655.27-1483.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
10,8964,3834,4968,21618,2246,457
Capital Expenditures
-1,015-786.53-2,139-1,885-3,173-1,674
Free Cash Flow
9,8813,5972,3576,33115,0514,783
Free Cash Flow Growth
536.46%52.60%-62.77%-57.94%214.66%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.52%40.37%41.07%30.88%32.72%23.58%
Operating Margin
7.73%5.05%-4.18%-3.32%6.80%-2.09%
Pretax Margin
5.25%2.41%-4.43%-11.40%0.12%-5.48%
Profit Margin
4.74%2.62%-4.35%-11.31%2.85%-5.21%
FCF Margin
7.67%2.91%1.97%4.59%9.11%3.41%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13.0834.12--32.02-
P/FCF Ratio
8.1430.7566.4440.4110.0144.23
PS Ratio
0.620.891.311.860.911.51